Tech Company Financing Transactions

Cypris Therapeutics Funding Round

Cypris Therapeutics closed a $500 thousand Seed funding round on 6/25/2024. Backers included Ichor Life Sciences and private investors.

Transaction Overview

Announced On
6/25/2024
Transaction Type
Venture Equity
Amount
$500,000
Round
Seed
Investors

Ichor Life Sciences (Lead Investor)

Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.

Company Information

Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
831 James Street
Syracuse, NY 13203
USA
Email Address
Overview
Our mission is to create solutions where they are urgently needed. Our cutting edge technology can be applied towards a variety of diseases. However, our immediate focus is addressing deadly diseases which have no effective treatments (Brain, Colon, & Pancreatic cancers). We believe that these patients are long overdue for quality, life-saving therapies.
Profile
Cypris Therapeutics LinkedIn Company Profile
Social Media
Cypris Therapeutics Company Twitter Account
Company News
Cypris Therapeutics News
Facebook
Cypris Therapeutics on Facebook
YouTube
Cypris Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Kyle Parella
  Kyle Parella LinkedIn Profile  Kyle Parella Twitter Account  Kyle Parella News  Kyle Parella on Facebook
Chief Scientific Officer
Jim Frederich
  Jim Frederich LinkedIn Profile  Jim Frederich Twitter Account  Jim Frederich News  Jim Frederich on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/25/2024: Coder venture capital transaction
Next: 6/25/2024: IBISA venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record funding rounds that are announced publicly. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary